Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial (Q36200568)

12 August 2017

Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial (English)

1 reference

12 August 2017

0 references

Nunzio Crimi

3

0 references

Alberto A Papi

object named as

Alberto Papi

1

0 references

Leonardo M. Fabbri

object named as

Leonardo Fabbri

4

0 references

author name string

Gabriele Nicolini

2

1 reference

12 August 2017

Dario Olivieri

5

1 reference

12 August 2017

Andrea Rossi

6

1 reference

12 August 2017

Pierluigi Paggiaro

7

1 reference

12 August 2017

25 June 2012

1 reference

12 August 2017

1 reference

12 August 2017

13

1 reference

12 August 2017

54

1 reference

Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431221

Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down".

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431221

Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431221

Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431221

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431221

Supervised step-down of inhaled corticosteroids in the community – An observational study

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431221

Down-titration from high-dose combination therapy in asthma: Removal of long-acting beta(2)-agonist

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431221

Increasing doses of inhaled corticosteroids compared to adding long-acting inhaled beta2-agonists in achieving asthma control

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431221

Maintaining asthma control in persistent asthma: comparison of three strategies in a 6-month double-blind randomised study.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431221

Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431221

A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431221

Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431221

Step-down compared to fixed-dose treatment with inhaled fluticasone propionate in asthma

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431221

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431221

Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431221

Inhaled beclometasone dipropionate/formoterol extra-fine fixed combination in the treatment of asthma: evidence and future perspectives

22 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186/1465-9921-13-54

Thoracic society of Australia and New Zealand. Asthma management plan, 1989

21 January 2018

1 reference

12 December 2020

What are minimal important changes for asthma measures in a clinical trial?

1 reference

12 December 2020

Randomized comparison of strategies for reducing treatment in mild persistent asthma

1 reference

12 December 2020

Patient factors that physicians use to assign asthma treatment

1 reference

12 December 2020

Identifiers

DOI

10.1186/1465-9921-13-54

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference

12 August 2017

PubMed publication ID

22731754

1 reference